Form4insider filings, from the source

SEC Form 4 · accession 0001609351-18-000032

Spark Therapeutics, Inc. · ONCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John Furey
Officer — Chief Operating Officer
Period of report
Apr 17, 2018
Accepted (ET)
Apr 19, 2018 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockApr 17, 2018M2,277$49.74A2,277D
Common StockApr 17, 2018S2,277$82.50D0D
Common StockApr 18, 2018M11,000$49.74A11,000D
Common StockF2Apr 18, 2018S11,000$82.53D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F3$49.74Apr 17, 2018M2,277D—Nov 30, 2026Common Stock2,277137,723D
Employee Stock Option (right to buy)F3$49.74Apr 18, 2018M11,000D—Nov 30, 2026Common Stock11,000126,723D

Explanation of responses